<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2020</study_start_year><data_sharing_plan>IPD Sharing (as of August 2022): No</data_sharing_plan><condition>Adenomatous Polyps</condition><condition>Colonic Polyps</condition><condition>Polyp of Colon</condition><condition>Colo-rectal Cancer</condition><condition>Adenomatous Polyp of Colon</condition><condition>Polyps</condition><disease>Adenomatous Polyps</disease><disease>Polyp Of Colon</disease><disease>Colonic Polyps</disease><disease>Adenomatous Polyp Of Colon</disease><disease>Colo-rectal Cancer</disease><disease>Polyps</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2351723</full_dataset_link><location>United States</location><study_start_month>9</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm</name><description>The focus of the study is to evaluate impact of submucosal injection of EverLift in achieving complete resection during polypectomy of polyps 4-9mm during colonoscopy.</description><dates><creation>2020-09-15</creation></dates><accession>2351723</accession><cross_references><ClinicalTrials___gov>NCT04551014</ClinicalTrials___gov></cross_references></HashMap>